Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic review on mutation markers for bladder cancer diagnosis in urine.

BJU international - 1 Jan 2021

Hentschel Anouk E, van der Toom Emma E, Vis André N, Ket Johannes C F, Bosschieter Judith, Heymans Martijn W, van Moorselaar R Jeroen A, Steenbergen Renske D M, Nieuwenhuijzen Jakko A

Abstract excerpt

OBJECTIVES: To systematically summarise the available evidence on urinary bladder cancer (BC) mutation markers. Gene mutations are expected to provide novel biomarkers for urinary BC diagnosis. To date, evidence on urinary BC mutation markers has not proven sufficient to be adopted by clinical guidelines. In the present systematic review, diagnostic accuracy of urinary mutation analysis is separately assessed for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Sensitivity and Specificity

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32539176
DOI: 10.1111/bju.15137
PMCID: PMC7818192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic review on mutation markers for bladder cancer diagnosis in urine.PMID 32539176Read ↗

GALEAS™ Bladder Demonstrates High Sensitivity and Specificity for Detecting Bladder Cancer: Real-World Multicentre Data from UK NHS Haematuria ClinicsSemantic proximity Read ↗

TP53 Mutation for Prediction of Tumor Recurrence and Metastasis in Bladder Cancer PatientsSemantic proximity Read ↗

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Bladder cancer detection in urine by novel methylation markersSemantic proximity Read ↗

UroMark—a urinary biomarker assay for the detection of bladder cancerSemantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypesSemantic proximity Read ↗

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer ManagementSemantic proximity Read ↗

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read ↗

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.Semantic proximity Read ↗

A urine-based liquid biopsy for detection of upper tract urothelial carcinoma: a self-matched study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.